Would Bristol-Myers Squibb have to apply to the U.S. FDA to change Plavix's prescribing information if/when the FDA approves use as an anticoagulant instead of warfarin. BTW, that's the same pharmaceutical that currently owns the TM for Coumadin.
An inquiring mind wants to know.
An inquiring mind wants to know.